coronary arteriosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patients undergoing coronary artery bypass surgery with cardiopulmonary bypass operated by the same surgeons; 2. ASA: II-IV; 3. NYHA: II-III; 4. Age: 40-70 years, sex unlimited; 5. The patients who have fully understood the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. History of cardiac surgery or congenital heart disease; 2. Diabetes mellitus;severe hypertension;severe liver dysfunction or kidney dysfunction;history of nervous systeym disease, mental or coagulaton dysfunction; 3. Obesity (BMI greater than 30); 4. History of long-term taking antibiotics or glucocorticoids;history of taking antibiotics, glucocorticoids or free radical scavenger at 1 month preoperatively; 5. Cardiac failure (LVEF less than 30%);severe arrhythmia preoperatively; 6. Combined with inflammatory reponse preopertively (infection, active arthritis or malignant tumor); 7. The patient have involved in clinical tests about other drugs for nearly 4 weeks; 8. The operation time: longer than 8 hours or shoter than 4 hours; the CPB time: longer than 3 hours or shoter than 1 hours; the heart is completely stopped during operation; two or more times CPB in operation; the clinical data is incomplete; 9. The researchers don't think there is any suitable for inclusion for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Troponin I;Creative kinase-MB; | — |
Secondary
| Measure | Time frame |
|---|---|
| The concentration of hydrogen gas;Interleukin-6;High mobility group box 1;Superoxide dismutase;Malondialdehyde;NF-kB; | — |
Countries
China